Table 2.
Objective outcomes at baseline and six months, by group
| Outcome Measure | N | Control Group | Exercise Group | Tx Effect | p-value2 | Cohen’s d | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | 6mo | Baseline | 6mo | Diff.1 | Baseline | 6mo | Diff.1 | ||||
| Cardiorespiratory Fitness Test Results | |||||||||||
| V̇O2 peak (mL/kg) | 15 | 13 | 13.93 | 12.7 | −0.1 | 13.43 | 13.8 | 0.0 | 0.1 | .920 | 0.06 |
| Resting heart rate (BPM) | 15 | 13 | 71.9 | 75.1 | 2.9 | 79.1 | 82.5 | 4.0 | 1.1 | .867 | 0.13 |
| Maximum Exercise heart rate (BPM) | 15 | 13 | 151 | 157 | 12 | 147 | 1194 | −25 | −37 | .284 | −1.14 |
| Maximum respiratory exchange ratio | 15 | 13 | 1.19 | 1.19 | −0.02 | 1.15 | 1.22 | 0.01 | 0.03 | .810* | 0.20 |
| Maximum Rating of Perceived Exertion | 15 | 13 | 18.4 | 17.4 | −0.9 | 17.1 | 16.7 | −0.5 | 0.4 | .809 | 0.16 |
| Total Exercise Time (minutes) | 15 | 13 | 11.6 | 11.4 | 0.3 | 10.2 | 10.4 | −0.4 | −0.7 | .590* | −0.37 |
| Power Output (W) | 15 | 13 | 73.8 | 67.1 | −2.9 | 68.6 | 73.3 | 0.0 | 2.9 | .660 | 0.30 |
| Cardiometabolic Risk Factors | |||||||||||
| Weight (lbs) | 15 | 13 | 194 | 197 | 2 | 201 | 206 | −2 | −3 | .607 | −0.43 |
| Body Mass Index | 15 | 13 | 29.3 | 29.9 | 0.3 | 29.3 | 30.1 | 0.7 | 0.4 | .664 | 0.38 |
| Waist (inches) | 15 | 13 | 43.1 | 43.7 | −0.3 | 43.0 | 42.7 | −1.1 | −0.8 | .715 | −0.30 |
| Systolic blood pressure (mmHg) | 15 | 13 | 116 | 125 | 9 | 125 | 125 | 3 | −6 | .472 | −0.50 |
| Diastolic blood pressure (mmHg) | 15 | 13 | 74.5 | 77.7 | 2.6 | 79.6 | 79.0 | 2.0 | −0.6 | .898 | −0.08 |
| Fasting HDL (mg/dl) | 15 | 13 | 41.6 | 40.0 | −0.1 | 39.4 | 37.8 | 0.8 | 1 | .777 | 0.20 |
| Fasting LDL (mg/dl) | 15 | 13 | 121 | 125 | −2 | 119 | 110 | −7 | −5 | .790 | −0.23 |
| Fasting Triglycerides (mg/dl) | 15 | 13 | 112 | 122 | 6 | 141 | 173 | 20 | 15 | .656* | 0.36 |
| HDL:LDL | 15 | 13 | 0.37 | 0.33 | 0.00 | 0.34 | 0.34 | 0.00 | −0.00 | .988 | −0.01 |
| Total Cholesterol:HDL | 15 | 13 | 4.67 | 4.86 | −0.07 | 5.01 | 5.19 | −0.03 | 0.05 | .947 | 0.06 |
| Total Triglyceride:HDL | 15 | 13 | 2.95 | 3.25 | 0.09 | 4.06 | 5.87 | 1.34 | 1.25 | .513* | 0.61 |
| Insulin Sensitivity Index | 14 | 13 | 5.89 | 6.64 | 0.93 | 4.28 | 5.05 | −0.13 | −1.07 | .402 | −0.59 |
| HOMA-Insulin Resistance | 14 | 13 | 1.95 | 1.70 | −0.33 | 4.03 | 4.19 | 0.41 | 0.74 | .437 | 0.71 |
| DXA Fat Mass (g) | 15 | 13 | 76.9 | 81.6 | 1.6 | 77.1 | 77.4 | −0.1 | −1.7 | .736 | −0.30 |
| DXA Lean Mass (g) | 15 | 13 | 105 | 103 | −1 | 111 | 116 | −1 | −0 | .957 | −0.04 |
Notes: Effect sizes of 0.5 or more in the expected direction are bolded. BPM = beats per minute
Mean difference based on all participants who had both a baseline and 6-month value for the specified measure
T-test significance (equal variances not assumed). Starred p-values failed the Shapiro-Wilk test for normality.
Baseline means for V̇O2 peak after excluding the two cases without 6-month data are 12.9 (controls) and 13.8 (exercise group).
Two participants with HR = 0, these are missing values and not an indication of cardiac arrest.